Prostate cancer and acromegaly (Q37686151)

22 August 2017

1 reference

title

Prostate cancer and acromegaly (English)

1 reference

22 August 2017

1 reference

7

Mônica R Gadelha

1 reference

22 August 2017

1

Lívia L Corrêa

1 reference

22 August 2017

Giovanna A Balarini Lima

2

1 reference

22 August 2017

Helena B de Melo Paiva

3

1 reference

22 August 2017

Cíntia M Dos Santos Silva

4

1 reference

22 August 2017

Suzana A Cavallieri

5

1 reference

22 August 2017

Luiz Carlos D de Miranda

6

1 reference

22 August 2017

1 November 2009

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

22 August 2017

1 reference

22 August 2017

53

1 reference

22 August 2017

8

1 reference

22 August 2017

963-968

1 reference

Etiologic aspects and management of acromegaly

22 August 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Acromegaly: re-thinking the cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Prostatic hyperplasia: an unknown feature of acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

The pathogenesis of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

[Molecular biology in the prostate neoplasia].

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

The endocrinology and developmental biology of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin receptor substrate-4 enhances insulin-like growth factor-I-induced cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Molecular and cellular aspects of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

The IGF axis and programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Acromegaly and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Acromegaly and cancer risk: a cohort study in Sweden and Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Increased incidence of neoplasia in females with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Oncological complications of excess GH in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800009

10.1590/S0004-27302009000800009

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference